Deal Announced at Livinity’s Annual Convention, Held July 13-14 in Kansas City, MO

SAN DIEGO–Growing direct-selling conglomerate Youngevity^® Essential Life Sciences (www.Youngevity.com) announces that it has entered into a sales and marketing alliance with Livinity^™, Inc. (www.Livinity.com), a Russell, Kansas-based direct seller of health and wellness products. The alliance will integrate Livinity’s established product line along with its 10,000 distributors and customers. Youngevity is a wholly-owned subsidiary of AL International (PINKSHEETS: JCOF) (www.alintjcof.com), a global marketer of lifestyle and nutritional products and gourmet fortified coffee.

Livinity is a direct-selling health and wellness company with a strong focus on pain management, stress relief and energy. Founded in 1996 by David Pitcock and Barb Pitcock, the company is dedicated to empowering its distributors and customers via a wide variety of personal care products as well as nutritional supplements. Livinity’s key product lines include Stress-ESE Plus, Livinity RELIEF Pain Gel & Capsules, and BlueREZ Healthy Energy Shots. As a result of the agreement, distributors and customers from both Livinity and Youngevity will have access to both of their products and services.

The agreement with Youngevity was announced at Livinity’s annual convention with over 500 attendees, “Livinity’s Leap to the Future,” held July 13-14 at the Holiday Inn KCI Airport Expo Center in Kansas City, Missouri. To make the announcement, Dr. Joel Wallach, co-founder of Youngevity, was joined on stage by company executives including Bill Andreoli, President; Dr. Dennis H. Harris, medical director of Livinity; and the Pitcocks.

“This agreement is the latest step in Youngevity’s long-term growth strategy of bringing superior health and wellness products to our distribution base,” commented Steve Wallach, CEO of AL International. “We are delighted that Livinity has agreed to join the Youngevity family, given the obvious synergies between our two companies. The Pitcocks share our vision for growth and will be a strong addition to our team with their impressive 15-year track record of building successful direct selling companies. We are confident that our synergies will drive growth and we look forward to expanding our distribution.”

“The range of Youngevity’s products and the strength of their distribution infrastructure is a natural complement to our product line,” commented David Pitcock, President and CEO of Livinity. “We are dedicated to maintaining a strong focus on leveraging the influence of our direct selling experience, while simultaneously enjoying the benefits of a partnership with Youngevity’s growing business.”

About Youngevity® Essential Life Sciences

Youngevity Essential Life Sciences (www.Youngevity.com), headquartered in San Diego, CA, is a nutrition and lifestyle-related services company dedicated to promoting vibrant health and flourishing economics. Founded in 1997 by Drs. Joel Wallach, DVM, ND, and Ma Lan, MD, as AL Global, Inc., the company adopted the name Youngevity in 2006. Youngevity is the only network marketing company to have a qualified FDA Health Claim. Dr. Wallach’s work has been published in more than 70 peer-reviewed and referenced scientific journals and books.

About AL International

AL International, Inc. (PINKSHEETS: JCOF) (www.alintjcof.com) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a “network of networks.” The company also is a vertically integrated producer of the finest coffees for the commercial, retail and direct sales channels. AL International was formed after the merger of Youngevity Essential Life Sciences (www.Youngevity.com) and Javalution Coffee Company in the summer of 2011.

Safe Harbor Statement

This release includes forward-looking statements on our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements relating to our business plan and growth strategy through acquisition. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in our forward-looking statements include, among others, the ability to implement our business plan and growth strategy through acquisition and the continued growth of our distributor base. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

SOURCE: BUSINESS WIRE